44 What's more, anergic cells Typically keep a better susceptibility to apoptosis Unless of course anti-apoptotic proteins like BCL2 are overexpressed, as is the situation for CLL cells.45 Without a doubt, most significant therapeutic advancements occurring in the last ten years are associated with the inhibition of BCR and BCL2-mediated signaling.